# TransMedics Group, Inc. (TMDX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from TransMedics Group, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TMDX/mda/fy2025/): filed 2026-02-24; accession 0001193125-26-067032 (https://www.sec.gov/Archives/edgar/data/1756262/000119312526067032/tmdx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TMDX/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-029104 (https://www.sec.gov/Archives/edgar/data/1756262/000095017025029104/tmdx-20241231.htm)
- [FY 2023 MD&A](/company/TMDX/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021155 (https://www.sec.gov/Archives/edgar/data/1756262/000095017024021155/tmdx-20231231.htm)
- [FY 2022 MD&A](/company/TMDX/mda/fy2022/): filed 2023-02-27; accession 0000950170-23-004652 (https://www.sec.gov/Archives/edgar/data/1756262/000095017023004652/tmdx-20221231.htm)
- [FY 2021 MD&A](/company/TMDX/mda/fy2021/): filed 2022-03-01; accession 0001564590-22-008045 (https://www.sec.gov/Archives/edgar/data/1756262/000156459022008045/tmdx-10k_20211231.htm)

Back to /company/TMDX/